Cardiff Names Interim Medical Chief Ahead of Phase III
Cardiff Oncology named Leila Alland interim chief medical officer on 27 October after Roger Sidhu stepped down. The change precedes a company-guided first-quarter 2027 Phase III start in RAS-mutated metastatic colorectal cancer. The reason…
